.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Merck
US Department of Justice
QuintilesIMS
Fish and Richardson
Chinese Patent Office
Citi
Moodys
Harvard Business School
Accenture

Generated: December 16, 2017

DrugPatentWatch Database Preview

AVENTYL Drug Profile

« Back to Dashboard

Which patents cover Aventyl , and what generic alternatives are available?

Aventyl is a drug marketed by Ranbaxy and Lilly and is included in two NDAs.

The generic ingredient in AVENTYL is nortriptyline hydrochloride. There are eleven drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.
Drug patent expirations by year for AVENTYL

Medical Subject Heading (MeSH) Categories for AVENTYL

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
RanbaxyAVENTYL nortriptyline hydrochlorideSOLUTION;ORAL014685-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
LillyAVENTYL HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL014684-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
LillyAVENTYL HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL014684-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
QuintilesIMS
Federal Trade Commission
Queensland Health
Citi
Chinese Patent Office
Harvard Business School
Colorcon
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot